Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Mainz, Rheinland-Pfalz, Germany
Founded Date: 2008-01-01
Investor Type: N/A
Investment Stage: N/A
Last Funding Date: 2022-04-14
Total Funding: 1741003260.0
Technology: COVID
Employee Number: N/A
Number Of Exists: N/A
Acquisitions Number: Made Acquisitions
Estimated Revenue: $100M to $500M
Investors Number: 4
Industry: mRNA-based Cancer Vaccines